SZ-685C, a novel anthracycline compound, as evidenced in this study, is able to potently suppress the phosphorylation of Akt and subsequently induce apoptosis in ADR-resistant breast cancer cells in which Akt kinase is over-activated. Here, AKT1 is linked to breast carcinoma.